Norepinephrine and epinephrine responses to physiological and pharmacological stimulation in chronic fatigue syndrome

Biological Psychology

Volumn 94, Issue 1, 2013, Pages 160-166

  Strahler, Jana ^a   Fischer, Susanne ^a   Nater, Urs M ^a   Ehlert, Ulrike ^b   Gaab, Jens ^c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Autonomic nervous system; Catecholamines; Chronic fatigue syndrome; Exercise test; Insulin Tolerance Test; Stress

Indexed keywords

ADRENALIN; INSULIN; NORADRENALIN;

ADRENAL MEDULLA; ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; BICYCLE ERGOMETRY; BLOOD ANALYSIS; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN TOLERANCE TEST; MALE; NORADRENALIN BLOOD LEVEL; PHYSICAL STRESS; PRIORITY JOURNAL; SYMPATHETIC TONE;

AUTONOMIC NERVOUS SYSTEM; CATECHOLAMINES; CHRONIC FATIGUE SYNDROME; EXERCISE TEST; INSULIN TOLERANCE TEST; STRESS;

ADULT; ANALYSIS OF VARIANCE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; BODY MASS INDEX; EPINEPHRINE; EXERCISE TEST; FATIGUE SYNDROME, CHRONIC; FEMALE; HEART RATE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NOREPINEPHRINE;

EID: 84880370801     PISSN: 03010511     EISSN: 18736246     Source Type: Journal    
DOI: 10.1016/j.biopsycho.2013.06.002     Document Type: Article

References (49)

1. Bazelmans E., Bleijenberg G., Van Der Meer J.W., Folgering H. Is physical deconditioning a perpetuating factor in chronic fatigue syndrome? A controlled study on maximal exercise performance and relations with fatigue, impairment and physical activity. Psychological Medicine 2001, 31(1):107-114.
2. Bearn J., Allain T., Coskeran P., Munro N., Butler J., McGregor A., et al. Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Biological Psychiatry 1995, 37(4):245-252.
3. Boneva R.S., Decker M.J., Maloney E.M., Lin J.M., Jones J.F., Helgason H.G., et al. Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: A population-based study. Autonomic Neuroscience 2007, 137(1-2):94-101.
4. Borg G.A. Psychophysical bases of perceived exertion. Medicine and Science in Sports and Exercise 1982, 14(5):377-381.
5. Buchner A., Faul F., Erdfelder E. G-Power: A priori, post-hoc, and compromise power analyses for the Macintosh (version 2. 1. 2) 1997, University of Trier, Trier, Germany.
6. Danese A., Pariante C.M., Caspi A., Taylor A., Poulton R. Childhood maltreatment predicts adult inflammation in a life-course study. Proceedings of the National Academy of Sciences USA 2007, 104(4):1319-1324.
7. De Lorenzo F., Hargreaves J., Kakkar V.V. Pathogenesis and management of delayed orthostatic hypotension in patients with chronic fatigue syndrome. Clinical Autonomic Research 1997, 7(4):185-190.
8. Dimsdale J.E., Moss J. Plasma catecholamines in stress and exercise. Journal of the American Medical Association 1980, 243(4):340-342.
9. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: The brain and the immune system. Pharmacological Reviews 2000, 52(4):595-638.
10. Evans G.W., English K. The environment of poverty: Multiple stressor exposure, psychophysiological stress, and socioemotional adjustment. Child Development 2002, 73(4):1238-1248.
11. Fries E., Hesse J., Hellhammer J., Hellhammer D.H. A new view on hypocortisolism. Psychoneuroendocrinology 2005, 30(10):1010-1016.
12. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Annals of Internal Medicine 1994, 121(12):953-959.
13. Gaab J., Engert V., Heitz V., Schad T., Schurmeyer T.H., Ehlert U. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome. Journal of Psychosomatic Research 2004, 56(4):419-424.
14. Gibson H., Carroll N., Clague J.E., Edwards R.H. Exercise performance and fatiguability in patients with chronic fatigue syndrome. Journal of Neurology, Neurosurgery, and Psychiatry 1993, 56(9):993-998.
15. Goldstein D.S. Plasma norepinephrine during stress in essential hypertension. Hypertension 1981, 3(5):551-556.
16. Goldstein D.S., McCarthy R., Polinsky R.J., Kopin I.J. Relationship between plasma norepinephrine and sympathetic neural activity. Hypertension 1983, 5(4):552-559.
17. Goldstein D.S. Adrenal responses to stress. Cellular and Molecular Neurobiology 2010, 30(8):1433-1440.
18. Heim C., Newport D.J., Heit S., Graham Y.P., Wilcox M., Bonsall R., et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. Journal of the American Medical Association 2000, 284(5):592-597.
19. Irwin M.R. Inflammation at the intersection of behavior and somatic symptoms. Psychiatric Clinics of North America 2011, 34(3):605-620.
20. Jammes Y., Steinberg J.G., Mambrini O., Bregeon F., Delliaux S. Chronic fatigue syndrome: Assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. Journal of Internal Medicine 2005, 257(3):299-310.
21. Kavelaars A., Kuis W., Knook L., Sinnema G., Heijnen C.J. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. The Journal of Clinical Endocrinology and Metabolism 2000, 85(2):692-696.
22. Kvetnansky R., Sabban E.L., Palkovits M. Catecholaminergic systems in stress: Structural and molecular genetic approaches. Physiological Reviews 2009, 89(2):535-606.
23. Light A.R., Bateman L., Jo D., Hughen R.W., Vanhaitsma T.A., White A.T., et al. Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome. Journal of Internal Medicine 2012, 271(1):64-81.
24. Light A.R., White A.T., Hughen R.W., Light K.C. Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. The Journal of Pain 2009, 10(10):1099-1112.
25. Lin J.M., Resch S.C., Brimmer D.J., Johnson A., Kennedy S., Burstein N., et al. The economic impact of chronic fatigue syndrome in Georgia: Direct and indirect costs. Cost Effectiveness and Resource Allocation 2011, 9(1):1.
26. Lowry T.J., Pakenham K.I. Health-related quality of life in chronic fatigue syndrome: Predictors of physical functioning and psychological distress. Psychology, Health, and Medicine 2008, 13(2):222-238.
27. Lutgendorf S.K., Antoni M.H., Ironson G., Fletcher M.A., Penedo F., Baum A., et al. Physical symptoms of chronic fatigue syndrome are exacerbated by the stress of Hurricane Andrew. Psychosomatic Medicine 1995, 57(4):310-323.
28. Mills P.J., Dimsdale J.E. The promise of adrenergic receptor studies in psychophysiologic research II: Applications, limitations, and progress. Psychosomatic Medicine 1993, 55(5):448-457.
29. Montague T.J., Marrie T.J., Klassen G.A., Bewick D.J., Horacek B.M. Cardiac function at rest and with exercise in the chronic fatigue syndrome. Chest 1989, 95(4):779-784.
30. Nater U.M., Fischer S., Ehlert U. Stress as a pathophysiological factor in functional somatic syndromes. Current Psychiatry Reviews 2011, 7(2):152-169.
31. Nater U.M., Heim C.M., Raison C. Chronic fatigue syndrome. Handbook of Clinical Neurology 2012, 106:573-587.
32. Nater U.M., Wagner D., Solomon L., Jones J.F., Unger E.R., Papanicolaou D.A., et al. Coping styles in people with chronic fatigue syndrome identified from the general population of Wichita, KS. Journal of Psychosomatic Research 2006, 60(6):567-573.
33. Ottenweller J.E., Sisto S.A., McCarty R.C., Natelson B.H. Hormonal responses to exercise in chronic fatigue syndrome. Neuropsychobiology 2001, 43(1):34-41.
34. Pacak K., Baffi J.S., Kvetnansky R., Goldstein D.S., Palkovits M. Stressor-specific activation of catecholaminergic systems: Implications for stress-related hypothalamic-pituitary-adrenocortical responses. Advances in Pharmacology 1998, 42:561-564.
35. Reeves W.C., Jones J.F., Maloney E., Heim C., Hoaglin D.C., Boneva R.S., et al. Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Population Health Metrics 2007, 5:5.
36. Reyes M., Nisenbaum R., Hoaglin D.C., Unger E.R., Emmons C., Randall B., et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Archives of Internal Medicine 2003, 163(13):1530-1536.
37. Rief W., Barsky A.J. Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 2005, 30(10):996-1002.
38. Riley M.S., O'Brien C.J., McCluskey D.R., Bell N.P., Nicholls D.P. Aerobic work capacity in patients with chronic fatigue syndrome. British Medical Journal 1990, 301(6758):953-956.
39. Robertson D., Johnson G.A., Robertson R.M., Nies A.S., Shand D.G., Oates J.A. Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation 1979, 59(4):637-643.
40. Rowe P.C., Bou-Holaigah I., Kan J.S., Calkins H. Is neurally mediated hypotension an unrecognised cause of chronic fatigue?. Lancet 1995, 345(8950):623-624.
41. Silver A., Haeney M., Vijayadurai P., Wilks D., Pattrick M., Main C.J. The role of fear of physical movement and activity in chronic fatigue syndrome. Journal of Psychosomatic Research 2002, 52(6):485-493.
42. Sisto S.A., LaManca J., Cordero D.L., Bergen M.T., Ellis S.P., Drastal S., et al. Metabolic and cardiovascular effects of a progressive exercise test in patients with chronic fatigue syndrome. American Journal of Medicine 1996, 100(6):634-640.
43. Streeten D.H., Thomas D., Bell D.S. The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. The American Journal of the Medical Sciences 2000, 320(1):1-8.
44. Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Circulation 1996, 93(5):1043-1065. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.
45. Timmers H.J., Wieling W., Soetekouw P.M., Bleijenberg G., Van Der Meer J.W., Lenders J.W. Hemodynamic and neurohumoral responses to head-up tilt in patients with chronic fatigue syndrome. Clinical Autonomic Research 2002, 12(4):273-280.
46. VanNess J.M., Stevens S.R., Bateman L., Stiles T.L., Snell C.R. Postexertional malaise in women with chronic fatigue syndrome. Journal of Womens Health 2010, 19(2):239-244.
47. Wallman K.E., Morton A.R., Goodman C., Grove R. Physiological responses during a submaximal cycle test in chronic fatigue syndrome. Medicine and Science in Sports and Exercise 2004, 36(10):1682-1688.
48. White A.T., Light A.R., Hughen R.W., Vanhaitsma T.A., Light K.C. Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls. Psychosomatic Medicine 2012, 74(1):46-54.
49. Wittchen H.U., Pfister H. DIA-X-interviews 1997, Swets & Zeitlinger, Frankfurt.